A study of the intraocular pressure lowering effect of topical application of ripasudil in clinical practice

A study of the intraocular pressure lowering effect of topical application of ripasudil in clinical practice - IOP lowering effect of ripasudil in clinical practice

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025466

Enrollment

130

Registered

2017-02-15

Start date

2017-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Glaucoma patients, in whom a target IOP was not achieved despite usage of maximally tolerated numbers of anti-glaucoma medications and took ripadusil eyedrops for the first time during December 2014 and November 2015.

Exclusion criteria

Exclusion criteria: Patients who underwent laser suturelysis intoraocular surgery other than glaucoma surgery by 6 months after the initiation of ripasudil eyedrops.

Design outcomes

Primary

Measure	Time frame
Magnitude and percentage of IOP reduction 6 months after initiation of ripasudil application	—

Countries

Japan

Contacts

Public ContactYukako Inoue

Kobe University Graduate School of Medicine Department of Surgery, Division of Ophthalmology

ganka@med.kobe-u.ac.jp078-382-6048

Outcome results